Study on the Anticancer Activity of Prodigiosin from Variants of Serratia Marcescens QBN VTCC 910026

Figure 4

Inhibitory concentration of Prodigiosin (0.5; 1; 2; 4; 6; 8 and 10 μg/ml) on different cancer cell line KB, SK-LU-1, MCF7, H460 and HEPG2.